954Indexed trials
canonical disease area
Alzheimer's Disease
Intelligence
Alzheimer's Disease intelligence: 954 indexed trials, 213 recruiting studies, 536 sponsors across 61 countries.
213Recruiting
536Sponsors
61Countries
Leading sponsors
Avid Radiopharmaceuticals140 recruiting
Massachusetts General Hospital143 recruiting
Eli Lilly and Company123 recruiting
Pfizer110 recruiting
Johns Hopkins University114 recruiting
Merck Sharp & Dohme LLC101 recruiting
National Institute on Aging (NIA)101 recruiting
Hoffmann-La Roche91 recruiting
Wyeth is now a wholly owned subsidiary of Pfizer90 recruiting
National Taiwan University Hospital92 recruiting
Bristol-Myers Squibb82 recruiting
Indiana University82 recruiting
Geographic activity
United States462trials
France117trials
Canada92trials
United Kingdom77trials
Spain70trials
Germany60trials
Italy59trials
Australia53trials
China44trials
Sweden44trials
South Korea43trials
Netherlands42trials
Leading interventions
Donepezil16trials
florbetapir F 188trials
Memantine7trials
MRI6trials
Gantenerumab4trials
Flortaucipir F184trials
donepezil4trials
Donanemab4trials
Lecanemab4trials
Exercise4trials
BMS-7081634trials
SAM-5314trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.